Search research articles
Contact Us
Filters
Showing results (11-20 of 29) with videos related to
Page
of 3
Sort By:
Clinical & Experimental Metastasis
|
January 29, 2000
Alterations in proteolytic activity at low pH and its association with invasion: a theoretical model
S D Webb, J A Sherratt, R G Fish
Novartis Foundation Symposium
|
December 1, 2001
Modelling tumour acidity and invasion
S D Webb, J A Sherratt, R G Fish
Journal of Theoretical Biology
|
February 17, 1999
Mathematical modelling of tumour acidity: regulation of intracellular pH
S D Webb, J A Sherratt, R G Fish
Clinical Biochemistry
|
February 1, 1985
Acute phase glycoproteins in sera of patients with sarcomas receiving methotrexate infusion therapy
A K Yap, R G Fish, C W Keen
Cancer Research
|
July 1, 1987
Re: Pharmacokinetics and dosage reduction of cis-diammine(1,1-cyclobutanedicarboxylato)platinum in patients with impaired renal function
R G Fish, M D Shelley, H Griffiths, et al.
British Journal of Cancer
|
August 1, 1985
Cystic fluid-platinum kinetics in ovarian cancer patients: relevance to cis-dichlorodiammine platinum (II) sensitivity testing in vitro
M D Shelley, R G Fish, M Adams, et al.
European Journal of Cancer & Clinical Oncology
|
May 1, 1984
Serum haptoglobin and alpha 1-acid glycoprotein as indicators of the effectiveness of cis-diamminedichloroplatinum (CDDP) in ovarian cancer patients--a preliminary report
R G Fish, T S Gill, M Adams, et al.
Anti-Cancer Drugs
|
June 1, 2000
Structure-activity studies on gossypol in tumor cell lines
M D Shelley, L Hartley, P W Groundwater, et al.
European Journal of Cancer & Clinical Oncology
|
June 1, 1987
The clinical value of serum CA125 levels in ovarian cancer patients receiving platinum therapy
R G Fish, M D Shelley, T Maughan, et al.
Clinical Biochemistry
|
February 1, 1984
Changes in serum acute phase proteins in ovarian cancer patients receiving cis-diamminedichloroplatinum (CDDP) infusion therapy
R G Fish, T S Gill, M Adams, et al.
Page
of 3
Search research articles
Search
Showing results (11-20 of 29) with videos related to
Sort By:
Page
of 3
Clinical & Experimental Metastasis
|
January 29, 2000
Alterations in proteolytic activity at low pH and its association with invasion: a theoretical model
S D Webb, J A Sherratt, R G Fish
Novartis Foundation Symposium
|
December 1, 2001
Modelling tumour acidity and invasion
S D Webb, J A Sherratt, R G Fish
Journal of Theoretical Biology
|
February 17, 1999
Mathematical modelling of tumour acidity: regulation of intracellular pH
S D Webb, J A Sherratt, R G Fish
Clinical Biochemistry
|
February 1, 1985
Acute phase glycoproteins in sera of patients with sarcomas receiving methotrexate infusion therapy
A K Yap, R G Fish, C W Keen
Cancer Research
|
July 1, 1987
Re: Pharmacokinetics and dosage reduction of cis-diammine(1,1-cyclobutanedicarboxylato)platinum in patients with impaired renal function
R G Fish, M D Shelley, H Griffiths, et al.
British Journal of Cancer
|
August 1, 1985
Cystic fluid-platinum kinetics in ovarian cancer patients: relevance to cis-dichlorodiammine platinum (II) sensitivity testing in vitro
M D Shelley, R G Fish, M Adams, et al.
European Journal of Cancer & Clinical Oncology
|
May 1, 1984
Serum haptoglobin and alpha 1-acid glycoprotein as indicators of the effectiveness of cis-diamminedichloroplatinum (CDDP) in ovarian cancer patients--a preliminary report
R G Fish, T S Gill, M Adams, et al.
Anti-Cancer Drugs
|
June 1, 2000
Structure-activity studies on gossypol in tumor cell lines
M D Shelley, L Hartley, P W Groundwater, et al.
European Journal of Cancer & Clinical Oncology
|
June 1, 1987
The clinical value of serum CA125 levels in ovarian cancer patients receiving platinum therapy
R G Fish, M D Shelley, T Maughan, et al.
Clinical Biochemistry
|
February 1, 1984
Changes in serum acute phase proteins in ovarian cancer patients receiving cis-diamminedichloroplatinum (CDDP) infusion therapy
R G Fish, T S Gill, M Adams, et al.
Page
of 3